Table 5.
Analysis of the cross-sectional correlations relevant to this study in participants without and with prevalent diabetes at DHS-1
| Spearman’s correlation coefficients Prob>r under HO: Rho=O |
||||||
|---|---|---|---|---|---|---|
| Without prevalent DM |
With prevalent DM |
|||||
| ΔeGFR | CRP | SMg | ΔeGFR | CRP | SMg | |
| SMg | 0.06 | −0.04 | 1.00 | 0.25 | −0.14 | 1.00 |
| 0.01 | 0.06 | <0.001 | 0.06 | – | ||
| SBP | −0.05 | 0.21 | −0.00 | −0.10 | 0.15 | 0.03 |
| 0.02 | <0.001 | 0.99 | 0.16 | 0.04 | 0.66 | |
| DBP | −0.02 | 0.21 | −0.02 | −0.01 | 0.14 | 0.06 |
| 0.39 | <0.001 | 0.29 | 0.90 | 0.05 | 0.43 | |
| SGlu | 0.004 | 0.15 | 0.06 | −0.22 | 0.20 | −0.37 |
| 0.86 | <0.001 | 0.01 | 0.003 | 0.007 | <0.001 | |
| ΔeGFR | 1.00 | 0.004 | 0.06 | 1.00 | −0.05 | 0.25 |
| − | 0.87 | 0.01 | 0.47 | <0.001 | ||
Spearman’s correlation coefficients (top) and p values (bottom) are reported.
CRP, C reactive protein; DBP, diastolic blood pressure; DHS, Dallas Heart Study; DHS-1, DHS phase 1 (2000–2002); ΔeGFR, eGFR at DHS-2 minus eGFR at DHS-1; eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; SGlu, serum glucose; SMg, serum magnesium.